吡拉米司特 T23154
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 144035-83-6 | ¥1,220.00 | 询底价 |
10 mg | 144035-83-6 | ¥1,970.00 | 询底价 |
1 mg | 144035-83-6 | ¥497.00 | 询底价 |
100 mg | 144035-83-6 | ¥6,930.00 | 询底价 |
25 mg | 144035-83-6 | ¥3,330.00 | 询底价 |
50 mg | 144035-83-6 | ¥4,870.00 | 询底价 |
1 mL | 144035-83-6 | ¥1,330.00 | 询底价 |
2 mg | 144035-83-6 | ¥729.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Piclamilast
描述: Piclamilast (RP 73401) 是一种有效的磷酸二酯酶 4(PDE4)的抑制剂,对猪主动脉和可溶性嗜酸性粒细胞中的 IC50值分别为 16 nM 和 2 nM。
体外活性: Piclamilast pre-treatment significantly inhibited the changes in 23 genes via mechanisms involving AP-1 activation and c-Jun phosphorylation at Ser63[1]. The IC50s for Piclamilast was 16 nM and 2 nM in pig aorta and eosinophil soluble, respectively. Piclamilast exhibited IC50 values >100 μM, 40 μM, >100 μM, 14 μM for PDE1, PDE2, PDE3 and PDE5. Respectively[4].
体内活性: Initial in vivo studies conducted in severe combined immunodeficiency mice transplanted with NB4 leukemia cells indicate that the enhancing effect of piclamilast on ATRA-induced myeloid maturation translates into a therapeutic benefit[2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 30 mg/ml(78.69 mM)
关键字: RP73401 | RP-73401 | inhibit | Phosphodiesterase (PDE) | AML | RPR73401 | phosphodiesterase | PDE | Piclamilast | RPR-73401 | RAR | Inhibitor | ATRA | cAMP
相关产品: Mirodenafil dihydrochloride | Choline theophyllinate | Ginkgolide J | WAY127093B racemate | Dipyridamole | GSK256066 | PF-04822163 | Avanafil | Dasantafil | PDE9-IN-(S)-C33
相关库: Anti-Neurodegenerative Disease Compound Library | ReFRAME Related Library | Bioactive Compounds Library Max | Human Metabolite Library | Inhibitor Library | Metabolism Compound Library | Anti-Alzheimer's Disease Compound Library | Bioactive Compound Library
吡拉米司特 T23154信息由TargetMol中国为您提供,如您想了解更多关于吡拉米司特 T23154报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途